Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Europe's sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China.
At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc.
The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals.
In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems.
Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.
According to this study, over the next five years the Pulmonary Function Testing Systems market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 430 million by 2024, from US$ 340 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pulmonary Function Testing Systems business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Function Testing Systems market by product type, application, key manufacturers and key regions and countries.
This study considers the Pulmonary Function Testing Systems value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Portable PFT Systems
Complete PFT Systems
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Physical Examination Center
Physician Groups
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pulmonary Function Testing Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pulmonary Function Testing Systems market by identifying its various subsegments.
Focuses on the key global Pulmonary Function Testing Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pulmonary Function Testing Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pulmonary Function Testing Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Pulmonary Function Testing Systems . Industry analysis & Market Report on Pulmonary Function Testing Systems is a syndicated market report, published as Global Pulmonary Function Testing Systems Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pulmonary Function Testing Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.